7561.TWO Bioray Biotech Co., Ltd

Healthcare Drug Manufacturers - Specialty & Generic Taiwan OTC Exchange
16.00 TWD
Close of Nov 6, 2026
15.41 24.75
Market cap
TWD 473M
P/E
24.6x
P/B
1.17x
ROE
7.1%
Dividend yield
5.83%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 7561.TWO undervalued?

Graham number
Price16.00
Graham value14.12
Premium13.3%

7561.TWO trades 13.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bioray Biotech Co., Ltd fundamental analysis

No fundamental analysis for Bioray Biotech Co., Ltd yet.

Bioray Biotech Co., Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bioray Biotech Co., Ltd

Bioray Biotech Co., Ltd engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan. It provides testing services for oncology and immune profile, gut microbiome, and health insights; CIK Immune Cell Therapy; and supplements and micro-pellets, as well as ODM/OEM services. Bioray Biotech Co., Ltd was founded in 2005 and is based in Tainan City, Taiwan.

Full company profile